Research Site

Niagara Falls, Ontario L2H 1H5

1 studies enrolling now · 8 studies all time

What they study most

Asthma, Diabetes Mellitus, Type 2, Duodenal Ulcer, Elevated High-sensitivity C-Reactive Protein (hsCRP), Eosinophilic Esophagitis, Gastric Ulcer, Type 2 Diabetes, Weight Management

Studies at this site

• A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM — Recruiting now
• Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis — Running, not enrolling
• Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (KALOS) — Completed
• JUPITER - Crestor 20mg Versus Placebo in Prevention of Cardiovascular (CV) Events — Stopped early
• Study of Esomeprazole 20 mg or 40 mg vs Placebo Effectiveness on the Occurrence of Peptic Ulcers in Subjects on Low Dose Acetylsalicylic Acid (LDA) — Completed
• GALLANT 6 Tesaglitazar vs. Pioglitazone — Stopped early
• GALLEX 6: Study to Evaluate the Safety and Tolerability of Tesaglitazar in Patients With Type 2 Diabetes Mellitus — Stopped early
• G-PLUS (GALLANT, GALLEX and ARMOR - Post Treatment Follow-up Study) — Stopped early